Barclays raised the firm’s price target on Edwards Lifesciences (EW) to $99 from $95 and keeps an Overweight rating on the shares. The firm increased estimates post the Q3 beat.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW: